99 related articles for article (PubMed ID: 15516756)
21. Design, synthesis and biological evaluation of novel 7-mercaptocoumarin derivatives as α(1)-adrenoceptor antagonists.
Xie SS; Wang XB; Li JY; Kong LY
Chem Pharm Bull (Tokyo); 2013; 61(1):16-24. PubMed ID: 23302583
[TBL] [Abstract][Full Text] [Related]
22. Design, synthesis and biological activity evaluation of arylpiperazine derivatives for the treatment of neuropathic pain.
Chen Y; Wang G; Xu X; Liu BF; Li J; Zhang G
Molecules; 2011 Jul; 16(7):5785-806. PubMed ID: 21738106
[TBL] [Abstract][Full Text] [Related]
23. Synthesis and biological evaluation of piperazine-based derivatives as inhibitors of plasminogen activator inhibitor-1 (PAI-1).
Ye B; Chou YL; Karanjawala R; Lee W; Lu SF; Shaw KJ; Jones S; Lentz D; Liang A; Tseng JL; Wu Q; Zhao Z
Bioorg Med Chem Lett; 2004 Feb; 14(3):761-5. PubMed ID: 14741285
[TBL] [Abstract][Full Text] [Related]
24. Antiarrhythmic and α-Adrenoceptor Antagonistic Properties of Novel Arylpiperazine Derivatives of Pyrrolidin-2-one.
Zaręba P; Dudek M; Lustyk K; Siwek A; Starowicz G; Bednarski M; Nowiński L; Zygmunt M; Sapa J; Malawska B; Kulig K
Arch Pharm (Weinheim); 2015 Dec; 348(12):861-7. PubMed ID: 26523954
[TBL] [Abstract][Full Text] [Related]
25. Synthesis of androgen receptor antagonists containing a pentafluorosulfanyl (SF
Jin J; Zhou Y; Yang D; Zhang Q; Wang MW; Lu W
Arch Pharm (Weinheim); 2018 Nov; 351(11):e1800175. PubMed ID: 30318752
[TBL] [Abstract][Full Text] [Related]
26. Synthesis and in vitro activity of N'-cyano-4-(2-phenylacetyl)-N-o-tolylpiperazine-1-carboximidamide P2X7 antagonists.
Morytko MJ; Betschmann P; Woller K; Ericsson A; Chen H; Donnelly-Roberts DL; Namovic MT; Jarvis MF; Carroll WA; Rafferty P
Bioorg Med Chem Lett; 2008 Mar; 18(6):2093-6. PubMed ID: 18272365
[TBL] [Abstract][Full Text] [Related]
27. Design, synthesis, and biological evaluation of novel 2-methylpiperazine derivatives as potent CCR5 antagonists.
Hu S; Wang Z; Hou T; Ma X; Li J; Liu T; Xie X; Hu Y
Bioorg Med Chem; 2015 Mar; 23(5):1157-68. PubMed ID: 25638498
[TBL] [Abstract][Full Text] [Related]
28. Design, synthesis, and biological evaluation of 4-phenylpyrrole derivatives as novel androgen receptor antagonists.
Yamamoto S; Matsunaga N; Hitaka T; Yamada M; Hara T; Miyazaki J; Santou T; Kusaka M; Yamaoka M; Kanzaki N; Furuya S; Tasaka A; Hamamura K; Ito M
Bioorg Med Chem; 2012 Jan; 20(1):422-34. PubMed ID: 22094279
[TBL] [Abstract][Full Text] [Related]
29. Synthesis and biological evaluation of benzodioxanylpiperazine derivatives as potent serotonin 5-HT(1A) antagonists: the discovery of Lecozotan.
Childers WE; Abou-Gharbia MA; Kelly MG; Andree TH; Harrison BL; Ho DM; Hornby G; Huryn DM; Potestio L; Rosenzweig-Lipson SJ; Schmid J; Smith DL; Sukoff SJ; Zhang G; Schechter LE
J Med Chem; 2005 May; 48(10):3467-70. PubMed ID: 15887953
[TBL] [Abstract][Full Text] [Related]
30. Synthesis and evaluation of pyridazinylpiperazines as vanilloid receptor 1 antagonists.
Tafesse L; Sun Q; Schmid L; Valenzano KJ; Rotshteyn Y; Su X; Kyle DJ
Bioorg Med Chem Lett; 2004 Nov; 14(22):5513-9. PubMed ID: 15482915
[TBL] [Abstract][Full Text] [Related]
31. 1-alkyl-4-acylpiperazines as a new class of imidazole-free histamine H(3) receptor antagonists.
Zaragoza F; Stephensen H; Knudsen SM; Pridal L; Wulff BS; Rimvall K
J Med Chem; 2004 May; 47(11):2833-8. PubMed ID: 15139761
[TBL] [Abstract][Full Text] [Related]
32. Identification of high-affinity P2Y₁₂ antagonists based on a phenylpyrazole glutamic acid piperazine backbone.
Zech G; Hessler G; Evers A; Weiss T; Florian P; Just M; Czech J; Czechtizky W; Görlitzer J; Ruf S; Kohlmann M; Nazaré M
J Med Chem; 2012 Oct; 55(20):8615-29. PubMed ID: 22984835
[TBL] [Abstract][Full Text] [Related]
33. Learning from estrogen receptor antagonism: structure-based identification of novel antiandrogens effective against multiple clinically relevant androgen receptor mutants.
Liu B; Geng G; Lin R; Ren C; Wu JH
Chem Biol Drug Des; 2012 Mar; 79(3):300-12. PubMed ID: 22151347
[TBL] [Abstract][Full Text] [Related]
34. The design and synthesis of novel, potent and orally bioavailable N-aryl piperazine-1-carboxamide CCR2 antagonists with very high hERG selectivity.
Cumming JG; Bower JF; Waterson D; Faull A; Poyser PJ; Turner P; McDermott B; Campbell AD; Hudson J; James M; Winter J; Wood C
Bioorg Med Chem Lett; 2012 Jun; 22(12):3895-9. PubMed ID: 22608963
[TBL] [Abstract][Full Text] [Related]
35. Discovery and Identification of Pyrazolopyramidine Analogs as Novel Potent Androgen Receptor Antagonists.
Wang L; Song T; Wang X; Li J
Front Pharmacol; 2018; 9():864. PubMed ID: 30210333
[TBL] [Abstract][Full Text] [Related]
36. Design, synthesis, and biological evaluation of the combinatorial library with a new spirodiketopiperazine scaffold. Discovery of novel potent and selective low-molecular-weight CCR5 antagonists.
Habashita H; Kokubo M; Hamano S; Hamanaka N; Toda M; Shibayama S; Tada H; Sagawa K; Fukushima D; Maeda K; Mitsuya H
J Med Chem; 2006 Jul; 49(14):4140-52. PubMed ID: 16821774
[TBL] [Abstract][Full Text] [Related]
37. Discovery of biphenyl piperazines as novel and long acting muscarinic acetylcholine receptor antagonists.
Jin J; Budzik B; Wang Y; Shi D; Wang F; Xie H; Wan Z; Zhu C; Foley JJ; Webb EF; Berlanga M; Burman M; Sarau HM; Morrow DM; Moore ML; Rivero RA; Palovich M; Salmon M; Belmonte KE; Lainé DI
J Med Chem; 2008 Oct; 51(19):5915-8. PubMed ID: 18798607
[TBL] [Abstract][Full Text] [Related]
38. Novel potent neuropeptide Y Y5 receptor antagonists: synthesis and structure-activity relationships of phenylpiperazine derivatives.
Takahashi T; Sakuraba A; Hirohashi T; Shibata T; Hirose M; Haga Y; Nonoshita K; Kanno T; Ito J; Iwaasa H; Kanatani A; Fukami T; Sato N
Bioorg Med Chem; 2006 Nov; 14(22):7501-11. PubMed ID: 16919461
[TBL] [Abstract][Full Text] [Related]
39. Design, synthesis and biological evaluation of novel arylpiperazine derivatives on human prostate cancer cell lines.
Chen H; Xu F; Liang X; Xu BB; Yang ZL; He XL; Huang BY; Yuan M
Bioorg Med Chem Lett; 2015 Jan; 25(2):285-7. PubMed ID: 25488843
[TBL] [Abstract][Full Text] [Related]
40. Synthesis and pharmacological evaluation of carbamic acid 1-phenyl-3-(4-phenyl-piperazine-1-yl)-propyl ester derivatives as new analgesic agents.
Chae E; Yi H; Choi Y; Cho H; Lee K; Moon H
Bioorg Med Chem Lett; 2012 Apr; 22(7):2434-9. PubMed ID: 22386241
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
